Selected research
Market Outlook & Growth Opportunities
Global Algal Toxin Testing Market Outlook and Growth Opportunities 2026
Market perspective
The global Algal Toxin Testing market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.
The North America market for Algal Toxin Testing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Algal Toxin Testing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Algal Toxin Testing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
In China, the Algal Toxin Testing market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Major global companies in the Algal Toxin Testing market include SGS, Eurofins, NIWA, Australian Water Quality Centre, Analytical Services Tasmania, Enviroscience, Microbac Laboratories, Alloway and Lifeasible, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.
This report provides an overview of the global Algal Toxin Testing market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Algal Toxin Testing and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Algal Toxin Testing revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Algal Toxin Testing market.
Algal Toxin Testing Segment by Company
SGS
Eurofins
NIWA
Australian Water Quality Centre
Analytical Services Tasmania
Enviroscience
Microbac Laboratories
Alloway
Lifeasible
Attogene
GreenWater Laboratories
EcoAnalysts
Symbio Laboratories
Babcock Laboratories
Tap Score
BlueGreenTest
National Pond Service
Gold Standard Diagnostics
Algal Toxin Testing Segment by Type
On Site Service
Online Services
Algal Toxin Testing Segment by Application
Government
Environmental Organizations
Enterprise
Individual
Algal Toxin Testing Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global Algal Toxin Testing status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the Algal Toxin Testing key companies, revenue, market share, and recent developments.
3. To split the Algal Toxin Testing breakdown data by regions, type, companies, and application.
4. To analyze the global and key regions Algal Toxin Testing market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Algal Toxin Testing significant trends, drivers, influence factors in global and regions.
6. To analyze Algal Toxin Testing competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Algal Toxin Testing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Algal Toxin Testing and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Algal Toxin Testing.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Algal Toxin Testing industry.
Chapter 3: Detailed analysis of Algal Toxin Testing company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales value of Algal Toxin Testing in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.
Chapter 7: Sales value of Algal Toxin Testing in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 9: Concluding Insights.
More report detail
Tables and figures
Scope & coverage.
Types
- On Site Service
- Online Services
Applications
- Government
- Environmental Organizations
- Enterprise
- Individual
Companies covered
- SGS
- Eurofins
- NIWA
- Australian Water Quality Centre
- Analytical Services Tasmania
- Enviroscience
- Microbac Laboratories
- Alloway
- Lifeasible
- Attogene
- GreenWater Laboratories
- EcoAnalysts
- Symbio Laboratories
- Babcock Laboratories
- Tap Score
- BlueGreenTest
- National Pond Service
- Gold Standard Diagnostics
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Algal Toxin Testing Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Algal Toxin Testing Market Size (2021-2032)
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Algal Toxin Testing Market Dynamics
- 2.1 Algal Toxin Testing Industry Trends
- 2.2 Algal Toxin Testing Industry Drivers
- 2.3 Algal Toxin Testing Industry Opportunities and Challenges
- 2.4 Algal Toxin Testing Industry Restraints
3 Algal Toxin Testing Market by Company
- 3.1 Global Algal Toxin Testing Company Revenue Ranking in 2025
- 3.2 Global Algal Toxin Testing Revenue by Company (2021-2026)
- 3.3 Global Algal Toxin Testing Company Ranking (2024-2026)
- 3.4 Global Algal Toxin Testing Company Manufacturing Base and Headquarters
- 3.5 Global Algal Toxin Testing Company Product Type and Application
- 3.6 Global Algal Toxin Testing Company Establishment Date
- 3.7 Market Competitive Analysis
- 3.7.1 Global Algal Toxin Testing Market Concentration Ratio (CR5 and HHI)
- 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
- 3.7.3 2025 Algal Toxin Testing Tier 1, Tier 2, and Tier 3 Companies
- 3.8 Mergers and Acquisitions Expansion
4 Algal Toxin Testing Market by Type
- 4.1 Algal Toxin Testing Type Introduction
- 4.1.1 On Site Service
- 4.1.2 Online Services
- 4.2 Global Algal Toxin Testing Sales Value by Type
- 4.2.1 Global Algal Toxin Testing Sales Value by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Algal Toxin Testing Sales Value by Type (2021-2032)
- 4.2.3 Global Algal Toxin Testing Sales Value Share by Type (2021-2032)
5 Algal Toxin Testing Market by Application
- 5.1 Algal Toxin Testing Application Introduction
- 5.1.1 Government
- 5.1.2 Environmental Organizations
- 5.1.3 Enterprise
- 5.1.4 Individual
- 5.2 Global Algal Toxin Testing Sales Value by Application
- 5.2.1 Global Algal Toxin Testing Sales Value by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Algal Toxin Testing Sales Value by Application (2021-2032)
- 5.2.3 Global Algal Toxin Testing Sales Value Share by Application (2021-2032)
6 Algal Toxin Testing Regional Value Analysis
- 6.1 Global Algal Toxin Testing Sales Value by Region: 2021 VS 2025 VS 2032
- 6.2 Global Algal Toxin Testing Sales Value by Region (2021-2032)
- 6.2.1 Global Algal Toxin Testing Sales Value by Region: 2021-2026
- 6.2.2 Global Algal Toxin Testing Sales Value by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Algal Toxin Testing Sales Value (2021-2032)
- 6.3.2 North America Algal Toxin Testing Sales Value Share by Country, 2025 VS 2032
- 6.4 Europe
- 6.4.1 Europe Algal Toxin Testing Sales Value (2021-2032)
- 6.4.2 Europe Algal Toxin Testing Sales Value Share by Country, 2025 VS 2032
- 6.5 Asia-Pacific
- 6.5.1 Asia-Pacific Algal Toxin Testing Sales Value (2021-2032)
- 6.5.2 Asia-Pacific Algal Toxin Testing Sales Value Share by Country, 2025 VS 2032
- 6.6 South America
- 6.6.1 South America Algal Toxin Testing Sales Value (2021-2032)
- 6.6.2 South America Algal Toxin Testing Sales Value Share by Country, 2025 VS 2032
- 6.7 Middle East & Africa
- 6.7.1 Middle East & Africa Algal Toxin Testing Sales Value (2021-2032)
- 6.7.2 Middle East & Africa Algal Toxin Testing Sales Value Share by Country, 2025 VS 2032
7 Algal Toxin Testing Country-level Value Analysis
- 7.1 Global Algal Toxin Testing Sales Value by Country: 2021 VS 2025 VS 2032
- 7.2 Global Algal Toxin Testing Sales Value by Country (2021-2032)
- 7.2.1 Global Algal Toxin Testing Sales Value by Country (2021-2026)
- 7.2.2 Global Algal Toxin Testing Sales Value by Country (2027-2032)
- 7.3 USA
- 7.3.1 USA Algal Toxin Testing Sales Value Growth Rate (2021-2032)
- 7.3.2 USA Algal Toxin Testing Sales Value Share by Type, 2025 VS 2032
- 7.3.3 USA Algal Toxin Testing Sales Value Share by Application, 2025 VS 2032
- 7.4 Canada
- 7.4.1 Canada Algal Toxin Testing Sales Value Growth Rate (2021-2032)
- 7.4.2 Canada Algal Toxin Testing Sales Value Share by Type, 2025 VS 2032
- 7.4.3 Canada Algal Toxin Testing Sales Value Share by Application, 2025 VS 2032
- 7.5 Mexico
- 7.5.1 Mexico Algal Toxin Testing Sales Value Growth Rate (2021-2032)
- 7.5.2 Mexico Algal Toxin Testing Sales Value Share by Type, 2025 VS 2032
- 7.5.3 Mexico Algal Toxin Testing Sales Value Share by Application, 2025 VS 2032
- 7.6 Germany
- 7.6.1 Germany Algal Toxin Testing Sales Value Growth Rate (2021-2032)
- 7.6.2 Germany Algal Toxin Testing Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Germany Algal Toxin Testing Sales Value Share by Application, 2025 VS 2032
- 7.7 France
- 7.7.1 France Algal Toxin Testing Sales Value Growth Rate (2021-2032)
- 7.7.2 France Algal Toxin Testing Sales Value Share by Type, 2025 VS 2032
- 7.7.3 France Algal Toxin Testing Sales Value Share by Application, 2025 VS 2032
- 7.8 U.K.
- 7.8.1 U.K. Algal Toxin Testing Sales Value Growth Rate (2021-2032)
- 7.8.2 U.K. Algal Toxin Testing Sales Value Share by Type, 2025 VS 2032
- 7.8.3 U.K. Algal Toxin Testing Sales Value Share by Application, 2025 VS 2032
- 7.9 Italy
- 7.9.1 Italy Algal Toxin Testing Sales Value Growth Rate (2021-2032)
- 7.9.2 Italy Algal Toxin Testing Sales Value Share by Type, 2025 VS 2032
- 7.9.3 Italy Algal Toxin Testing Sales Value Share by Application, 2025 VS 2032
- 7.10 Spain
- 7.10.1 Spain Algal Toxin Testing Sales Value Growth Rate (2021-2032)
- 7.10.2 Spain Algal Toxin Testing Sales Value Share by Type, 2025 VS 2032
- 7.10.3 Spain Algal Toxin Testing Sales Value Share by Application, 2025 VS 2032
- 7.11 Russia
- 7.11.1 Russia Algal Toxin Testing Sales Value Growth Rate (2021-2032)
- 7.11.2 Russia Algal Toxin Testing Sales Value Share by Type, 2025 VS 2032
- 7.11.3 Russia Algal Toxin Testing Sales Value Share by Application, 2025 VS 2032
- 7.12 Netherlands
- 7.12.1 Netherlands Algal Toxin Testing Sales Value Growth Rate (2021-2032)
- 7.12.2 Netherlands Algal Toxin Testing Sales Value Share by Type, 2025 VS 2032
- 7.12.3 Netherlands Algal Toxin Testing Sales Value Share by Application, 2025 VS 2032
- 7.13 Nordic Countries
- 7.13.1 Nordic Countries Algal Toxin Testing Sales Value Growth Rate (2021-2032)
- 7.13.2 Nordic Countries Algal Toxin Testing Sales Value Share by Type, 2025 VS 2032
- 7.13.3 Nordic Countries Algal Toxin Testing Sales Value Share by Application, 2025 VS 2032
- 7.14 China
- 7.14.1 China Algal Toxin Testing Sales Value Growth Rate (2021-2032)
- 7.14.2 China Algal Toxin Testing Sales Value Share by Type, 2025 VS 2032
- 7.14.3 China Algal Toxin Testing Sales Value Share by Application, 2025 VS 2032
- 7.15 Japan
- 7.15.1 Japan Algal Toxin Testing Sales Value Growth Rate (2021-2032)
- 7.15.2 Japan Algal Toxin Testing Sales Value Share by Type, 2025 VS 2032
- 7.15.3 Japan Algal Toxin Testing Sales Value Share by Application, 2025 VS 2032
- 7.16 South Korea
- 7.16.1 South Korea Algal Toxin Testing Sales Value Growth Rate (2021-2032)
- 7.16.2 South Korea Algal Toxin Testing Sales Value Share by Type, 2025 VS 2032
- 7.16.3 South Korea Algal Toxin Testing Sales Value Share by Application, 2025 VS 2032
- 7.17 India
- 7.17.1 India Algal Toxin Testing Sales Value Growth Rate (2021-2032)
- 7.17.2 India Algal Toxin Testing Sales Value Share by Type, 2025 VS 2032
- 7.17.3 India Algal Toxin Testing Sales Value Share by Application, 2025 VS 2032
- 7.18 Australia
- 7.18.1 Australia Algal Toxin Testing Sales Value Growth Rate (2021-2032)
- 7.18.2 Australia Algal Toxin Testing Sales Value Share by Type, 2025 VS 2032
- 7.18.3 Australia Algal Toxin Testing Sales Value Share by Application, 2025 VS 2032
- 7.19 Southeast Asia
- 7.19.1 Southeast Asia Algal Toxin Testing Sales Value Growth Rate (2021-2032)
- 7.19.2 Southeast Asia Algal Toxin Testing Sales Value Share by Type, 2025 VS 2032
- 7.19.3 Southeast Asia Algal Toxin Testing Sales Value Share by Application, 2025 VS 2032
- 7.20 Brazil
- 7.20.1 Brazil Algal Toxin Testing Sales Value Growth Rate (2021-2032)
- 7.20.2 Brazil Algal Toxin Testing Sales Value Share by Type, 2025 VS 2032
- 7.20.3 Brazil Algal Toxin Testing Sales Value Share by Application, 2025 VS 2032
- 7.21 Argentina
- 7.21.1 Argentina Algal Toxin Testing Sales Value Growth Rate (2021-2032)
- 7.21.2 Argentina Algal Toxin Testing Sales Value Share by Type, 2025 VS 2032
- 7.21.3 Argentina Algal Toxin Testing Sales Value Share by Application, 2025 VS 2032
- 7.22 Chile
- 7.22.1 Chile Algal Toxin Testing Sales Value Growth Rate (2021-2032)
- 7.22.2 Chile Algal Toxin Testing Sales Value Share by Type, 2025 VS 2032
- 7.22.3 Chile Algal Toxin Testing Sales Value Share by Application, 2025 VS 2032
- 7.23 Colombia
- 7.23.1 Colombia Algal Toxin Testing Sales Value Growth Rate (2021-2032)
- 7.23.2 Colombia Algal Toxin Testing Sales Value Share by Type, 2025 VS 2032
- 7.23.3 Colombia Algal Toxin Testing Sales Value Share by Application, 2025 VS 2032
- 7.24 Peru
- 7.24.1 Peru Algal Toxin Testing Sales Value Growth Rate (2021-2032)
- 7.24.2 Peru Algal Toxin Testing Sales Value Share by Type, 2025 VS 2032
- 7.24.3 Peru Algal Toxin Testing Sales Value Share by Application, 2025 VS 2032
- 7.25 Saudi Arabia
- 7.25.1 Saudi Arabia Algal Toxin Testing Sales Value Growth Rate (2021-2032)
- 7.25.2 Saudi Arabia Algal Toxin Testing Sales Value Share by Type, 2025 VS 2032
- 7.25.3 Saudi Arabia Algal Toxin Testing Sales Value Share by Application, 2025 VS 2032
- 7.26 Israel
- 7.26.1 Israel Algal Toxin Testing Sales Value Growth Rate (2021-2032)
- 7.26.2 Israel Algal Toxin Testing Sales Value Share by Type, 2025 VS 2032
- 7.26.3 Israel Algal Toxin Testing Sales Value Share by Application, 2025 VS 2032
- 7.27 UAE
- 7.27.1 UAE Algal Toxin Testing Sales Value Growth Rate (2021-2032)
- 7.27.2 UAE Algal Toxin Testing Sales Value Share by Type, 2025 VS 2032
- 7.27.3 UAE Algal Toxin Testing Sales Value Share by Application, 2025 VS 2032
- 7.28 Turkey
- 7.28.1 Turkey Algal Toxin Testing Sales Value Growth Rate (2021-2032)
- 7.28.2 Turkey Algal Toxin Testing Sales Value Share by Type, 2025 VS 2032
- 7.28.3 Turkey Algal Toxin Testing Sales Value Share by Application, 2025 VS 2032
- 7.29 Iran
- 7.29.1 Iran Algal Toxin Testing Sales Value Growth Rate (2021-2032)
- 7.29.2 Iran Algal Toxin Testing Sales Value Share by Type, 2025 VS 2032
- 7.29.3 Iran Algal Toxin Testing Sales Value Share by Application, 2025 VS 2032
- 7.30 Egypt
- 7.30.1 Egypt Algal Toxin Testing Sales Value Growth Rate (2021-2032)
- 7.30.2 Egypt Algal Toxin Testing Sales Value Share by Type, 2025 VS 2032
- 7.30.3 Egypt Algal Toxin Testing Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
- 8.1 SGS
- 8.1.1 SGS Company Information
- 8.1.2 SGS Business Overview
- 8.1.3 SGS Algal Toxin Testing Revenue and Gross Margin (2021-2026)
- 8.1.4 SGS Algal Toxin Testing Product Portfolio
- 8.1.5 SGS Recent Developments
- 8.2 Eurofins
- 8.2.1 Eurofins Company Information
- 8.2.2 Eurofins Business Overview
- 8.2.3 Eurofins Algal Toxin Testing Revenue and Gross Margin (2021-2026)
- 8.2.4 Eurofins Algal Toxin Testing Product Portfolio
- 8.2.5 Eurofins Recent Developments
- 8.3 NIWA
- 8.3.1 NIWA Company Information
- 8.3.2 NIWA Business Overview
- 8.3.3 NIWA Algal Toxin Testing Revenue and Gross Margin (2021-2026)
- 8.3.4 NIWA Algal Toxin Testing Product Portfolio
- 8.3.5 NIWA Recent Developments
- 8.4 Australian Water Quality Centre
- 8.4.1 Australian Water Quality Centre Company Information
- 8.4.2 Australian Water Quality Centre Business Overview
- 8.4.3 Australian Water Quality Centre Algal Toxin Testing Revenue and Gross Margin (2021-2026)
- 8.4.4 Australian Water Quality Centre Algal Toxin Testing Product Portfolio
- 8.4.5 Australian Water Quality Centre Recent Developments
- 8.5 Analytical Services Tasmania
- 8.5.1 Analytical Services Tasmania Company Information
- 8.5.2 Analytical Services Tasmania Business Overview
- 8.5.3 Analytical Services Tasmania Algal Toxin Testing Revenue and Gross Margin (2021-2026)
- 8.5.4 Analytical Services Tasmania Algal Toxin Testing Product Portfolio
- 8.5.5 Analytical Services Tasmania Recent Developments
- 8.6 Enviroscience
- 8.6.1 Enviroscience Company Information
- 8.6.2 Enviroscience Business Overview
- 8.6.3 Enviroscience Algal Toxin Testing Revenue and Gross Margin (2021-2026)
- 8.6.4 Enviroscience Algal Toxin Testing Product Portfolio
- 8.6.5 Enviroscience Recent Developments
- 8.7 Microbac Laboratories
- 8.7.1 Microbac Laboratories Company Information
- 8.7.2 Microbac Laboratories Business Overview
- 8.7.3 Microbac Laboratories Algal Toxin Testing Revenue and Gross Margin (2021-2026)
- 8.7.4 Microbac Laboratories Algal Toxin Testing Product Portfolio
- 8.7.5 Microbac Laboratories Recent Developments
- 8.8 Alloway
- 8.8.1 Alloway Company Information
- 8.8.2 Alloway Business Overview
- 8.8.3 Alloway Algal Toxin Testing Revenue and Gross Margin (2021-2026)
- 8.8.4 Alloway Algal Toxin Testing Product Portfolio
- 8.8.5 Alloway Recent Developments
- 8.9 Lifeasible
- 8.9.1 Lifeasible Company Information
- 8.9.2 Lifeasible Business Overview
- 8.9.3 Lifeasible Algal Toxin Testing Revenue and Gross Margin (2021-2026)
- 8.9.4 Lifeasible Algal Toxin Testing Product Portfolio
- 8.9.5 Lifeasible Recent Developments
- 8.10 Attogene
- 8.10.1 Attogene Company Information
- 8.10.2 Attogene Business Overview
- 8.10.3 Attogene Algal Toxin Testing Revenue and Gross Margin (2021-2026)
- 8.10.4 Attogene Algal Toxin Testing Product Portfolio
- 8.10.5 Attogene Recent Developments
- 8.11 GreenWater Laboratories
- 8.11.1 GreenWater Laboratories Company Information
- 8.11.2 GreenWater Laboratories Business Overview
- 8.11.3 GreenWater Laboratories Algal Toxin Testing Revenue and Gross Margin (2021-2026)
- 8.11.4 GreenWater Laboratories Algal Toxin Testing Product Portfolio
- 8.11.5 GreenWater Laboratories Recent Developments
- 8.12 EcoAnalysts
- 8.12.1 EcoAnalysts Company Information
- 8.12.2 EcoAnalysts Business Overview
- 8.12.3 EcoAnalysts Algal Toxin Testing Revenue and Gross Margin (2021-2026)
- 8.12.4 EcoAnalysts Algal Toxin Testing Product Portfolio
- 8.12.5 EcoAnalysts Recent Developments
- 8.13 Symbio Laboratories
- 8.13.1 Symbio Laboratories Company Information
- 8.13.2 Symbio Laboratories Business Overview
- 8.13.3 Symbio Laboratories Algal Toxin Testing Revenue and Gross Margin (2021-2026)
- 8.13.4 Symbio Laboratories Algal Toxin Testing Product Portfolio
- 8.13.5 Symbio Laboratories Recent Developments
- 8.14 Babcock Laboratories
- 8.14.1 Babcock Laboratories Company Information
- 8.14.2 Babcock Laboratories Business Overview
- 8.14.3 Babcock Laboratories Algal Toxin Testing Revenue and Gross Margin (2021-2026)
- 8.14.4 Babcock Laboratories Algal Toxin Testing Product Portfolio
- 8.14.5 Babcock Laboratories Recent Developments
- 8.15 Tap Score
- 8.15.1 Tap Score Company Information
- 8.15.2 Tap Score Business Overview
- 8.15.3 Tap Score Algal Toxin Testing Revenue and Gross Margin (2021-2026)
- 8.15.4 Tap Score Algal Toxin Testing Product Portfolio
- 8.15.5 Tap Score Recent Developments
- 8.16 BlueGreenTest
- 8.16.1 BlueGreenTest Company Information
- 8.16.2 BlueGreenTest Business Overview
- 8.16.3 BlueGreenTest Algal Toxin Testing Revenue and Gross Margin (2021-2026)
- 8.16.4 BlueGreenTest Algal Toxin Testing Product Portfolio
- 8.16.5 BlueGreenTest Recent Developments
- 8.17 National Pond Service
- 8.17.1 National Pond Service Company Information
- 8.17.2 National Pond Service Business Overview
- 8.17.3 National Pond Service Algal Toxin Testing Revenue and Gross Margin (2021-2026)
- 8.17.4 National Pond Service Algal Toxin Testing Product Portfolio
- 8.17.5 National Pond Service Recent Developments
- 8.18 Gold Standard Diagnostics
- 8.18.1 Gold Standard Diagnostics Company Information
- 8.18.2 Gold Standard Diagnostics Business Overview
- 8.18.3 Gold Standard Diagnostics Algal Toxin Testing Revenue and Gross Margin (2021-2026)
- 8.18.4 Gold Standard Diagnostics Algal Toxin Testing Product Portfolio
- 8.18.5 Gold Standard Diagnostics Recent Developments
9 Concluding Insights
10 Appendix
- 10.1 Reasons for Doing This Study
- 10.2 Research Methodology
- 10.3 Research Process
- 10.4 Authors List of This Report
- 10.5 Data Source
- 10.5.1 Secondary Sources
- 10.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst